Search Results - "Meilhac, O."

Refine Results
  1. 1

    HDL and endothelial protection by Tran‐Dinh, A, Diallo, D, Delbosc, S, Varela‐Perez, L Maria, Dang, QB, Lapergue, B, Burillo, E, Michel, JB, Levoye, A, Martin‐Ventura, JL, Meilhac, O

    Published in British journal of pharmacology (01-06-2013)
    “…High‐density lipoproteins (HDLs) represent a family of particles characterized by the presence of apolipoprotein A‐I (apoA‐I) and by their ability to transport…”
    Get full text
    Journal Article
  2. 2

    Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses by Garcia, C., Montée, N., Faccini, J., Series, J., Meilhac, O., Cantero, A.‐V., Le Faouder, P., Elbaz, M., Payrastre, B., Vindis, C.

    Published in Journal of thrombosis and haemostasis (01-05-2018)
    “…Essentials HDL subclasses were studied in acute coronary syndrome (ACS). HDL2 from ACS patients have better antiplatelet potency than HDL from non ACS…”
    Get full text
    Journal Article
  3. 3

    A disposable electrochemical sensor based on protein G for High-Density Lipoprotein (HDL) detection by Chammem, H., Hafaid, I., Bohli, N., Garcia, A., Meilhac, O., Abdelghani, A., Mora, L.

    Published in Talanta (Oxford) (01-11-2015)
    “…In this work, two biosensors were developed for the detection of High-Density Lipoproteins (HDL) particles, which are biomarkers inversely correlated with…”
    Get full text
    Journal Article
  4. 4

    Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms by Houard, X, Rouzet, F, Touat, Z, Philippe, M, Dominguez, M, Fontaine, V, Sarda-Mantel, L, Meulemans, A, Le Guludec, D, Meilhac, O, Michel, J-B

    Published in The Journal of pathology (01-05-2007)
    “…Development and progression of acquired abdominal aortic aneurysms (AAAs) involve proteolytic activity. In the present study, we investigate the distribution…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm by Ramos-Mozo, P, Rodriguez, C, Pastor-Vargas, C, Blanco-Colio, L.M, Martinez-Gonzalez, J, Meilhac, O, Michel, J-B, de Ceniga, M. Vega, Egido, J, Martin-Ventura, J.L

    Published in Atherosclerosis (01-04-2012)
    “…Highlights ► IGFBP-1 has been identified by a protein array as a novel biomarker of AAA. ► IGFBP-1 concentration are increased in AAA. ► IGFBP-1 levels…”
    Get full text
    Journal Article
  7. 7

    Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms by Martín-Ventura, J.L, Lindholt, J.S, Moreno, J.A, Vega de Céniga, M, Meilhac, O, Michel, J.B, Egido, J, Blanco-Colio, L.M

    Published in Atherosclerosis (01-02-2011)
    “…Abstract Objectives Diminished soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) concentrations are associated with cardiovascular…”
    Get full text
    Journal Article
  8. 8

    Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution by Martinez-Pinna, R, Lindholt, J.S, Blanco-Colio, L.M, Dejouvencel, T, Madrigal-Matute, J, Ramos-Mozo, P, Vega de Ceniga, M, Michel, J.B, Egido, J, Meilhac, O, Martin-Ventura, J.L

    Published in Atherosclerosis (01-09-2010)
    “…Abstract Objective Oxidative stress is a main mechanism involved in vascular pathologies. Increased thioredoxin (TRX) levels have been observed in several…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells by Kolb, S, Vranckx, R, Huisse, M-G, Michel, J-B, Meilhac, O

    Published in The Journal of pathology (01-07-2007)
    “…Apoptosis participates in every step of atherogenesis, but the process of clearance of apoptotic cells by phagocytosis has been underestimated. Rapid removal…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Biology of atherosclerotic plaques : What we are learning from proteomic analysis by BLANCO-COLIO, Luis Miguel, MARTIN-VENTURA, Jose Luis, VIVANCO, Fernando, MICHEL, Jean-Baptiste, MEILHAC, Olivier, EGIDO, Jesus

    Published in Cardiovascular research (01-10-2006)
    “…Atherosclerotic plaque rupture triggers the onset of cardiovascular complications such as myocardial infarction and stroke, which represent the main cause of…”
    Get full text
    Journal Article
  13. 13

    Lipid peroxides induce expression of catalase in cultured vascular cells by Meilhac, O, Zhou, M, Santanam, N, Parthasarathy, S

    Published in Journal of lipid research (01-08-2000)
    “…Various forms of oxidized low-density lipoproteins (Ox-LDL) are thought to play a major role in the development of atherosclerosis. The lipid components of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance by Roncal, C, Buysschaert, I, Chorianopoulos, EK, Georgiadou, M, Meilhac, O, Demol, M, Michel, J.B, Vinckier, S, Moons, L, Carmeliet, P

    Published in The Journal of pathology (01-10-2008)
    “…Recent evidence indicates that an imbalance between cardiomyocyte hypertrophy and blood vessel growth in the remote myocardium may contribute to heart failure…”
    Get full text
    Journal Article
  16. 16

    P102 Anticorps circulants dirigés contre les pathogènes parodontaux et récidive des événements cardiovasculaires chez des patients diabétiques et non diabétiques avec un infarctus du myocarde by Boillot, A, Range, H, Danchin, N, Kotti, S, Cosler, G, Czernichow, S, Meilhac, O, Puymirat, E, Zeller, M, Tchetche, D, Bouchard, P, Simon, T

    Published in Diabetes & metabolism (01-03-2015)
    “…Introduction La présence d’anticorps circulants dirigés contre les principaux pathogènes parodontaux a été associée à l’incidence d’événements coronariens chez…”
    Get full text
    Journal Article
  17. 17

    Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins by Meilhac, O. (INSERM, Toulouse, France.), Escargueil-Blanc, I, Thiers, J.C, Salvayre, R, Negre-Salvayre, A

    Published in The FASEB journal (01-03-1999)
    “…ABSTRACT Oxidized low density lipoproteins (ox‐LDL) participate in atherosclerosis plaque formation, rupture, and subsequent thrombosis. Because oxLDL are…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A009 Importance of tweak-CD163 system in peripheral artery disease by Moreno, J.-A, Smadja, D, Martin-Ventura, J.-L, Egido, J, Blanco-Colio, L.-M, Michel, J.-B, Meilhac, O

    “…Introduction CD163 is a macrophage receptor of haptoglogin/ haemoglobin complexes responsible for clearance of hemogloin. It has been recently suggested to be…”
    Get full text
    Journal Article
  20. 20

    A017 The biomarkers of coronary events study (biocore): from plasma sampling to discovery of new circulating biomarkers of atherosclerosis using differential proteomic analysis by Meilhac, O, Leger, T, Lavigne, D, Fareh, J, Guerrier, L, Boschetti, E, Laprevote, O, Michel, J.-B, Feldman, L

    “…In spite of important therapeutic advances during the last 20 years, coronary atherothrombotic complications are and will remain the first cause of death all…”
    Get full text
    Journal Article